HUDSON, N.H., Jan. 13, 2011 /PRNewswire/ — Atrium Medical
Corporation and Kaneka Corporation are proud to
announce the introduction of the Xpress-Way™ RX Extraction
Catheter. Xpress-Way RX has recently received FDA 510K clearance
and is indicated for the removal of fresh, soft emboli and thrombi
from vessels in the coronary and peripheral vasculature. The
Xpress-Way RX manual extraction catheter is manufactured by Kaneka
Corporation (Osaka, Japan) and Atrium Medical Corporation (Hudson,
NH) is the exclusive distributor of the Xpress-Way RX in the
U.S.
Thrombus aspiration uses the suction force generated from a
syringe to pull soft fresh thrombus from a vessel. Thrombus can
form throughout the body, but manual thrombus aspiration is
commonly used in patients that have heart attacks. The main cause
of heart attacks is due to a plaque rupture in one of the major
coronary arteries, which causes a blood clot to form reducing blood
flow and depriving the heart muscle downstream of oxygen rich
blood. Manual thrombus aspiration is one tool used by
interventional cardiologists to remove the blood clot and restore
critical blood flow to the heart muscle.
About Xpress-Way™ RX
The Xpress-Way™ RX Extraction Catheter is an ultra low
profile manual aspiration system designed for the removal of fresh,
soft emboli, and thrombi in both coronary and peripheral vessels.
Xpress-Way RX incorporates an innovative removable stylet and has
been designed with enhanced pushability, anti-kinking,
trackability, and crossability which allows for unmatched
deliverability and market leading performance. Outside the United
States, the Xpress-Way RX is marketed as the Thrombuster II (Kaneka
Corporation, Osaka, Japan).
About Atrium
Atrium’s vast expertise in medical device technologies for the
treatment of coronary and vascular disease, chest trauma, hernia
and soft tissue injury has brought a number o
‘/>”/>
